← Eichor
Condition: Short Bowel Syndrome Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Short Bowel Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
NA · 2 location(s) · Boston Children's Hospital · NCT03530852
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
Phase 2 · 14 location(s) · Hanmi Pharmaceutical Company Limited · NCT04775706
Fiber Food Introduction in Pediatric Short Bowel Syndrome
NA · 1 location(s) · Children's Hospital of Philadelphia · NCT05432648
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Phase 3 · 23 location(s) · Zealand Pharma · NCT07197944
Irritable Bowel Syndrome and Control Volunteers: Diet Challenge
NA · 1 location(s) · University of California, Los Angeles · NCT06668922
A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
Phase 3 · 4 location(s) · Takeda · NCT06973304
Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome
Phase 4 · 2 location(s) · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07691125
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
Phase N/A · 14 location(s) · Boston Children's Hospital · NCT04629014
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Co
Phase 2 · 8 location(s) · Napo Therapeutics, S.p.A. · NCT06904872
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in A
NA · 6 location(s) · Eclipse Regenesis, Inc. · NCT05535361
Elemental 028 Extra Case Studies
NA · 1 location(s) · Nutricia UK Ltd · NCT06877923
Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
Phase 1 · 1 location(s) · Central Hospital, Nancy, France · NCT05302531
A Clinical Study of FT1 in Patients With Short Bowel Syndrome
Phase 2 · 1 location(s) · Chongqing Peg-Bio Biopharm Co., Ltd. · NCT07704047
SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Question
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT06771505
Resting Energy Expenditure by Gastrointestinal Functional Status
NA · 1 location(s) · Institute of Oncology Ljubljana · NCT07714499
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168
A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome
Phase N/A · 4 location(s) · Takeda · NCT07319832
Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome
EARLY_Phase 1 · 1 location(s) · Lindsey Russell, MD · NCT06326645
TED_ORG: Study on Short Bowel Syndrome
NA · 1 location(s) · Meyer Children's Hospital IRCCS · NCT07400783
AGE Accumulation in Patients on Long-term Parenteral Nutrition
NA · 3 location(s) · University Hospital, Bordeaux · NCT07392801
Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT07713641
Kodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome
NA · 1 location(s) · JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RES · NCT07703371
Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
Phase 3 · 8 location(s) · Chongqing Peg-Bio Biopharm Co., Ltd. · NCT06512584
A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)
Phase N/A · 1 location(s) · Takeda · NCT05561647
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.